Key clinical point: The health care costs of patients with nonalcoholic fatty liver disease were nearly twice that of matched population controls.
Major finding: Annual hospitalizations averaged 0.27 times among patients with NAFLD vs. 0.16 times among controls matched by age, sex, and region (P less than .001), for an annual incremental cost of $635.
Study details: Retrospective study of 646 patients with biopsy-confirmed NAFLD and 6,460 matched population controls.
Disclosures: Funders included Stockholm City Council, the Bengt Ihre Foundation, the County Council of Östergötland, and Gilead, Inc. The researchers reported having no conflicts of interest.
Hagström H et al. Clin Gastroenterol Hepatol. 2019 Oct 18. doi: 10.1016/j.cgh.2019.10.023.